MidDiagnosed 2026-10-12 15:42:29 KSTAANIPAI Stock Diagnostic ReportANI Pharma reports positive phase 4 data for Iluvien in non-infectious uveitisANI Pharma's announcement of positive Phase 4 data for Iluvien, a non-infectious uveitis treatment, is expected to act as a positive catalyst for the stock price.View Source Article ↗ AI CATALYST SCORE65 / 100Score computed by Sentinel V12REFERENCE PRICENot measuredReference entry price at analysis time 👍 0🔥 0🤔 0🔗 0𝕏f🔗📤